SQI Diagnostics Inc. (CVE:SQD) Director Gerald R. Connor sold 189,000 shares of the stock in a transaction on Monday, December 11th. The shares were sold at an average price of C$0.16, for a total value of C$30,240.00.
SQI Diagnostics Inc. (CVE:SQD) remained flat at $C$0.19 during trading on Friday. The company’s stock had a trading volume of 14,720 shares, compared to its average volume of 65,529. The stock has a market cap of $19.74, a price-to-earnings ratio of -3.17 and a beta of 1.35. SQI Diagnostics Inc. has a fifty-two week low of C$0.10 and a fifty-two week high of C$0.24.
About SQI Diagnostics
SQI Diagnostics Inc (SQI) is a Canada-based diagnostics company. The Company develops multiplexed tests and automated systems for customers needing to measure a range of biomarkers in blood or other common sample types. It offers three different platforms sqidlite, sqid x and the siqdworks to run and analyze its microarray plates.
Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.